ClinicaliQ Trial Snapshot
- A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) — Active Not Recruiting • Phase II • Oncology • NCT05327530.
- Avelumab combined with other cancer drugs was tested as maintenance therapy in advanced bladder cancer to assess safety and effectiveness.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this study is to assess the safety and efficacy of avelumab in combination with other anti-tumor agents as a maintenance treatment in participants with bladder cancer. Conditions: Locally Advanced or Metastatic Urothelial Carcinoma Interventions: Avelumab, Sacituzumab Govitecan (SG), M6223, NKTR-255, JB100 Lead Sponsor: EMD Serono Research & Development Institute, Inc. Planned Enrollment: 256 participants